CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2020 No. 779, eff. 11-23-20; CR 22-011: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810.
CSB 2.012 NoteCSB 2.79 Addition of remimazolam to schedule IV. Section 961.20 (2) (mo), Stats., is created to read:
CSB 2.012 Note961.20 (2) (mo) Remimazolam;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register November 2020 No. 779, eff. 11-23-20; CR 22-014: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810.
CSB 2.012 NoteCSB 2.80 Scheduling of oliceridine. Section 961.16 (3) (ta), Stats., is created to read:
CSB 2.012 Note961.16 (3) (ta) Oliceridine;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register December 2020 No. 780, eff. 12-14-20; CR 21-098: cr. Register August 2022 No. 800, eff. 9-1-22.
CSB 2.012 NoteCSB 2.81 Addition of brorphine to schedule I. Section 961.14 (2) (et), Stats., is created to read:
CSB 2.012 Note961.14 (2) (et) Brorphine;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2021 No. 785, eff. 4-26-21; correction made under s. 35.17, Stats., Register May 2021 No. 785; CR 22-016: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810.
CSB 2.012 NoteCSB 2.82 Addition of Serdexmethylphenidate to schedule IV. Section 961.20 (2m) (em), Stats., is created to read:
CSB 2.012 Note961.20 (2m) (em) Serdexmethylphenidate.
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-12-21; CR 22-032: cr. Register June 2023 No. 810, eff. 7-1-23.
CSB 2.012 NoteCSB 2.83 Addition of ten (10) fentanyl-related substances to schedule I. Section 961.14 (2) (nd) 21., 22., 23., 24., 25., 26., 27., 28., 29., and 30., Stats., is created to read:
CSB 2.012 Note961.14 (2) (nd) 21. N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2’-fluoro ortho-fluorofentanyl; 2’-fluoro 2-fluorofentanyl);
CSB 2.012 Note22. N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4’-methyl acetyl fentanyl);
CSB 2.012 Note23. N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β’-phenyl fentanyl; beta’-Phenyl fentanyl; 3-phenylpropanoyl fentanyl);
CSB 2.012 Note24. N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide (β-methyl fentanyl);
CSB 2.012 Note25. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl);
CSB 2.012 Note26. N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
CSB 2.012 Note27. 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
CSB 2.012 Note28. N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);
CSB 2.012 Note29. N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl);
CSB 2.012 Note30. N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl).
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-033: cr. Register June 2023 No. 810, eff. 7-1-23.
CSB 2.012 NoteCSB 2.84 Addition of alfaxalone to schedule IV. (1) Section 961.20 (2) (a), Stat., is repealed and recreated to read:
CSB 2.012 Note961.20 (2) (a) Alfaxalone;
CSB 2.012 Note(2)  Section 961.20 (2) (ak) is created to read:
CSB 2.012 Note961.20 (2) (ak) Alprazolam;